Pages that link to "Q28379463"
Jump to navigation
Jump to search
The following pages link to Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. (Q28379463):
Displaying 28 items.
- Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration (Q24792432) (← links)
- HIV-1 pol diversity among female bar and hotel workers in Northern Tanzania (Q28540536) (← links)
- Unprecedented degree of human immunodeficiency virus type 1 (HIV-1) group M genetic diversity in the Democratic Republic of Congo suggests that the HIV-1 pandemic originated in Central Africa. (Q30327384) (← links)
- Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. (Q30331327) (← links)
- Use of sequence data generated in the Bayer Tru Gene genotyping assay to recognize and characterize non-subtype-b human immunodeficiency virus type 1 strains (Q31009699) (← links)
- Transmitted drug resistance in nonsubtype B HIV-1 infection (Q33567164) (← links)
- env Gene typing of human immunodeficiency virus type 1 strains on electronic microarrays (Q33753239) (← links)
- Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1. (Q33785338) (← links)
- Human immunodeficiency virus type 1 group m protease in cameroon: genetic diversity and protease inhibitor mutational features (Q33951471) (← links)
- Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda (Q33974239) (← links)
- Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. (Q34110204) (← links)
- The genetic variability of HIV-1 and its implications (Q34333843) (← links)
- HIV/AIDS treatment and HIV vaccines for Africa (Q34726113) (← links)
- Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains (Q34781852) (← links)
- High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis. (Q35156558) (← links)
- A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies (Q35742512) (← links)
- Virus subtype-specific features of natural simian immunodeficiency virus SIVsmm infection in sooty mangabeys (Q35947635) (← links)
- Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. (Q36423642) (← links)
- Drug resistance mutation profile and accumulation kinetics in human immunodeficiency virus-positive individuals infected with subtypes B and F failing highly active antiretroviral therapy are influenced by different viral codon usage patterns. (Q36993546) (← links)
- Development of phenotypic and genotypic resistance to antiretroviral therapy in the UNAIDS HIV drug access initiative – Uganda (Q38882677) (← links)
- Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran (Q39069184) (← links)
- Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients (Q39461924) (← links)
- Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG. (Q39626666) (← links)
- Drug Resistance Profiles of Recombinant Reverse Transcriptases from Human Immunodeficiency Virus Type 1 Subtypes A/E, B, and C (Q44636524) (← links)
- High prevalence and diversity of HIV-1 non-B genetic forms due to immigration in southern Spain: A phylogeographic approach (Q46209757) (← links)
- Prevalence and origin of HIV-1 group M subtypes among patients attending a Belgian hospital in 1999. (Q53973836) (← links)
- Biological and genetic characteristics of HIV infections in Cameroon reveals dual group M and O infections and a correlation between SI-inducing phenotype of the predominant CRF02_AG variant and disease stage (Q56831316) (← links)
- Near full genome characterization of HIV-1 unique recombinant forms in Cameroon reveals dominant CRF02_AG and F2 recombination patterns (Q92233898) (← links)